MedTrace Logo

Surgery in Addition to the Medical Treatment of Lymphedema

NCT03776214 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-03-10

No results posted yet for this study

Summary

Lymphedema is a chronic pathology with a real impact on the quality of life of patients. Despite optimal medical management of patients, some patients still have no pitting edema on which the medical treatment has no effect.

It is adipose tissue secondary to the evolution of lymphedema. It is often painful and important in terms of volume with the resulting functional consequences. The investigators propose to these patients a surgical management complementary to the optimal medical treatment by microlipoaspiration associated or not with a dermolipectomy. This surgical management began in 2014 in our service. The investigators want to evaluate the impact on quality of life of patients in this surgical management in addition to medical care.

Conditions

  • Optimal Treatment of Lymphedema

Sponsors & Collaborators

  • Department of Reconstructive surgery, UH Montpellier

    collaborator UNKNOWN

  • Department of vascular medecine, UH Montpellier

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • MESTRE GODIN Sandrine · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03776214 on ClinicalTrials.gov